News & Updates

Older women with cervical cancer face bleak outcomes

07 Dec 2021

Cervical cancer stands out as a major concern for older women who are frequently undertreated and are at higher risk of death, a study reports.

Older women with cervical cancer face bleak outcomes

07 Dec 2021

Levetiracetam associated with longer OS in IDH wild-type glioblastoma

07 Dec 2021 by

An observational single-institution cohort study provides evidence that levetiracetam use throughout the duration of standard chemotherapy is associated with longer median overall survival (OS) in patients with isocitrate dehydrogenase (IDH) wild-type glioblastoma.

Levetiracetam associated with longer OS in IDH wild-type glioblastoma

07 Dec 2021

Environmental ills linked to aggressive prostate cancer diagnosis

06 Dec 2021

Poor environmental quality is associated with greater odds of an advanced stage prostate cancer at diagnosis, with a study finding the strongest associations for lower water, land, sociodemographic quality.

Environmental ills linked to aggressive prostate cancer diagnosis

06 Dec 2021

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

06 Dec 2021

Enrolment in clinical trials does not seem to increase survival among patients with multiple myeloma, a recent study has found.

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

06 Dec 2021

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

06 Dec 2021

In the second-line treatment of patients advanced oesophageal cancer, the use of programmed cell death 1 (PD-1) inhibitors yields more favourable outcomes than chemotherapy across multiple patient subgroups, according to the results of a meta-analysis.

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

06 Dec 2021

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

05 Dec 2021

Cisplatin-based adjuvant chemotherapy confers substantial survival benefit in patients with muscle-invasive bladder cancer, reports a recent meta-analysis of randomized controlled trials (RCT).

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

05 Dec 2021

Long-term renal function decline common following radical cystectomy for bladder cancer

05 Dec 2021

Renal function considerably decreases over the long term for most bladder cancer patients who underwent radical cystectomy, a study has found.

Long-term renal function decline common following radical cystectomy for bladder cancer

05 Dec 2021

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma

03 Dec 2021

Temozolomide administered to patients with glioblastoma at full actual body weight dosing during the concurrent phase is necessary to achieve a median overall survival (OS) that is similar to that seen in a previous trial, according to a recent study.

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma

03 Dec 2021

MiR-146a levels show good prognostic, diagnostic value in ALL

02 Dec 2021

The circulating levels of microRNA (miR)-146a is a potential noninvasive biomarker for the diagnosis and prognosis of acute lymphoblastic leukaemia (ALL) in both paediatric and adult patients, a recent study has found.

MiR-146a levels show good prognostic, diagnostic value in ALL

02 Dec 2021

Does statin affect performance of PSA screening?

02 Dec 2021 by

Prostate-specific antigen (PSA) screening was associated with similar decrease in incidence of advanced prostate cancer (PCa) among statin users vs nonusers, but less detection of low-grade localized tumours in the former than the latter — indicating that statin does not compromise the benefits of PSA-based screening while also conferring the benefit of less overdiagnosis of low-risk tumours.

Does statin affect performance of PSA screening?

02 Dec 2021

News & Updates

Filter by Specialty:

Specialty:

Older women with cervical cancer face bleak outcomes

Older women with cervical cancer face bleak outcomes

Levetiracetam associated with longer OS in IDH wild-type glioblastoma

Levetiracetam associated with longer OS in IDH wild-type glioblastoma

Environmental ills linked to aggressive prostate cancer diagnosis

Environmental ills linked to aggressive prostate cancer diagnosis

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

Long-term renal function decline common following radical cystectomy for bladder cancer

Long-term renal function decline common following radical cystectomy for bladder cancer

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma

MiR-146a levels show good prognostic, diagnostic value in ALL

MiR-146a levels show good prognostic, diagnostic value in ALL

Does statin affect performance of PSA screening?

Does statin affect performance of PSA screening?